Outside the United States (English)
Adjustable Continence Therapy for Stress Urinary Incontinence
Stress incontinence, or the accidental loss of bladder control, is an enormous silent health issue that affects 12 million women and 2 million men worldwide. Adjustable Continence Therapy (ACT® Therapy for women and ProACT™ Therapy for men) from Uromedica, Inc. is designed to treat stress urinary incontinence with confidence. It is being implanted in Europe, Canada, Asia, South America and Australia. (Commercially Available Outside the United States Only.)
Patients
Women
ACT is a minimally invasive implant designed to treat stress urinary incontinence in women who have not had success with other treatments. 
Physicians
ACT Therapy for Women
Adjustable Continence Therapy (ACT®) is a minimally invasive urological implant designed to treat female patients who have stress urinary incontinence.
ProACT Therapy for Men
ProACT™ Therapy is a minimally invasive urological implant designed to treat male patients who have stress urinary incontinence following radical prostatectomy for prostate cancer or transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH).
—This page last modified Thursday November 20, 2008